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The T4 phage proteins Mre11 and Rad50, also known as gp46 and gp47, are responsible 
for the detection of DNA double-strand break and initiation of its repair.  Mre11 carries 
out the nuclease and strand annealing activities at the site of damage while Rad50, an 
ATPase, regulates the nuclease activity of Mre11. Mutation in either protein can lead to 
the loss of DNA repair function and, in humans, this leads to various forms of cancer, 
neurological disorders, and immunological deficiencies. Although crystal structures of 
Mre11-Rad50 complex have been reported, the precise mechanism of communication 
between the two partner proteins in executing the DNA repair remains poorly understood. 
We carried out in vitro biophysical characterization of the solution behavior of the T4 
Mre11/Rad50 proteins using hydrogen-deuterium exchange followed by mass 
spectrometry. Based on our study, we propose a new model for domain arrangement of 
T4Mre11/Rad50 proteins in the complex. Our model is found to differ from the models 
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1.1 DNA Damage and Repair  
Genomic stability, which is essential for maintenance of homeostasis in cells, is 
constantly put at risk by DNA damage. Such damage can result from endogenous agents 
such as reactive oxygen species generated during cellular processes or from exogenous 
agents such as UV radiation or chemotherapeutics (1-4). DNA damage can be broadly 
categorized into single-strand breaks, double-strand breaks, base modifications, and 
bulky lesions (5). Deletion, mismatch of bases, and translocation of fragments are some 
of the most frequently occurring DNA damages. Repair of such damages is essential to 
prevent production of aberrant gene products and transmission of miscoded genetic 
information to progeny, which leads to developmental abnormalities or cancer, 
neurological , and immunological disorders (2, 6-8). Extensive studies have been carried 
out to decipher the molecular events occurring during the repair process and to identify 
constituent proteins involved  in the signaling events (5, 8, 9). The repair pathways differ, 
based on the kind of damage and the developmental stage of the affected cell (10). If the 
damage is extensive and irreversible, cells are directed to the apoptotic pathway for 
elimination from the system (6). Figures 1.1 and 1.2 depict the four major responses to 
DNA damage in mammalian cells and the repair pathways followed depending on the 




Figure 1.1: DNA damage response pathway in mammalian cells. Based on the nature of 
damage, either of these pathways could function independently or in combination with 
one another. 
 
Figure 1.2: DNA damage can be broadly classified into three: single strand breaks 
(SSB), bulky lesions and double strand breaks (DSB). A. Single-strand damage involves 
breaks in one of the DNA strands or chemical modification of a single base (red 
hexagon). Such damages follow the single-strand repair or base excision repair pathway 
(section 1.2) B. Lesions (cyan sphere) that involve chemical modification of the 
backbone leads to disruption of the helix backbone and these damages are repaired by 
nucleotide-excision repair pathway (section 1.2). C. DSBs: Bifunctional reagents that 
lead to interstrand cross-links (grey dumbbell) or external agents like radical oxygen 
species lead to break of both the strands and the damage is subsequently repaired by non-
homologous or homologous recombination pathway based on the development stage of 
the cell (section 1.3).(Source: McKinnon PJ, 2009 (3)) 
A B C 
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1.2 Single-Strand DNA Repair 
Single-strand DNA (ssDNA) repair involves excising either small number of nucleotides 
(when the damage is restricted to a single base) through the base excision repair (BER) 
pathway or a long stretch of DNA through the nucleotide excision repair (NER) pathway, 
respectively. 
BER: This involves a lesion-specific DNA glycosylase and an endonuclease that excises 
the base followed by recruitment of other enzymes such as APE1 endonuclease, 
scaffolding protein XRCC1 (X-ray repair complementing defective repair in Chinese 
hamster cells 1) and poly ADP-ribose polymerase (PARP). These proteins along with 
DNA polymerase, fill in the gap. The strands are then ligated by ligase III/I based on the 
length of the patch (Figure 1.3) (11, 12). 
NER: There are of two kinds. When the repair occurs during transcription and involves 
Transcription factor II H (TFIIH), transcription and repair complex, it is referred to as 
transcription-coupled repair (TCR). In other cases, the repair is termed as global genomic 
repair (GGR) (13, 14). These two pathways mainly differ in the proteins involved in the 
initial damage recognition process. XPC (xeroderma pigmentosum, complementation 
group C)/XPE (also known as DNA binding protein 1) is known to initiate the genomic 
repair pathway while CSB (Cockayne Syndrome B) is required to initiate transcription-
coupled repair. Subsequent steps of repair are similar in both the pathways. The damage 
verification and DNA unwinding is carried out by TFIIH, XPD, XPG, and XPA proteins, 
by formation of a pre-incision complex. The nuclease activity of XPG causes incision to 
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occur, which is followed by gap-filling by DNA polymerase and rejoining by ligase I or 
III (Figure 1.4). 
 
Figure 1.3: Base excision repair. SSBs arising due to DNA glycosylase action or direct 
damage lead to recruitment of poly ADP-ribose polymerase 1 (PARP1) at the damage 
site, which subsequently activates scaffolding protein XRCC1, DNA polymerase (Polβ), 
DNA ligase (LIG3) and apurinic/apyrimidinic endonuclease 1 (APE1). Based on the 
length of nucleotides that is to be excised the protein machinery involved differs. Repair 
of longer stretches is carried out by LIG1 and PCNA. Also, in some cases based on the 
nature of damage at the SSB, tyrosyl DNA phosphodiesterase 1(TDP1) or aprataxin 
(APTX) is recruited. TDP1 acts on 3′ modified ends or topoisomerase I DNA adducts 
while APTX acts on 5′ ends resulting from abortive ligation events. (Source: McKinnon 




Figure 1.4: Nucleotide Excision Repair pathway. The primary steps involved in NER are 
recognition of the damage, excision and repair synthesis. Two different pathways within 
NER differ in recognition step. When the damage is recognized during transcription and 
involves transcription factors (TFIIH) it is termed as transcription coupled repair (TCR). 
Else, it is referred to as global genomic repair. Post recognition, the repair steps followed 
in both the pathways is similar.  The colored blocks on the right highlight the disorders 
resulting from dysfunctional proteins of the NER pathway. (Source: McKinnon PJ, 2009 
(3) ) 
1.3 Double-Strand DNA Repair  
Double-strand break (DSB) repair occurs through one of two major pathways, 
homologous recombination (HR) or non-homologous end joining (NHEJ). Multiple 
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proteins are involved in sensing the DSB, which help in arresting the cell cycle and 
activating the necessary repair pathway.  
 
Figure 1.5: Double strand break repair pathway. Homologous recombination occurs in 
proliferating cells. The replication protein A (RPA) and recombinase Rad51 coat the 
broken double strand ends and initiates repair by formation of the holliday junction with 
the help of the sister chromatid, which serves a template ensuring a error-free repair. 
NHEJ occurs in differentiated cells that lacks a reference template. It involves key 
proteins like KU70 and KU80, which modify the damaged end and prepare it for 
ligation. Ligation is further carried out by ligase IV (LIG4), XRCC4, and other proteins. 
(Source: McKinnon PJ, 2009 (3).  
HR functions mainly in proliferating cells during the S and G2 phases of the cell cycle. 
This repair process involves a sister chromatid which is used as template for correcting 
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the damaged DNA and hence in most cases error-free. The repair is carried out by 
Mre11-Rad50-Nbs1 (MRN) protein complex— the protein of our interest. MRN in 
association with BRCA1 C-terminal interacting protein (CTIP), generates a 3’ single-
stranded DNA (ssDNA). Replication protein A (RPA) and the recombinase Rad51 coat 
the ssDNA generated, initiates formation of a holliday junction intermediate using the 
template DNA from the sister chromatid for the repair to proceed (Figure 1.5). 
NHEJ is a DSB repair pathway observed in non-replicating or differentiated cells that 
lack a reference template. This increases chance of error during the repair process. NHEJ 
repair involves modification of the two broken DNA ends so that they are compatible for 
direct ligation. The end modification is carried out by DNA protein kinase complex 
(DNA-PK), KU70, KU80 (ATP-dependent DNA helicases), and associated end-
processing factors (Figure 1.5). The ligation is catalyzed by DNA ligase IV (LIG4) in 
conjunction with XRCC4 and Cernunnos.  
 
1.4 Cell Cycle Checkpoint Response Control by ATM and ATR during DSB 
DSB repair is associated with signaling events that prevent cell proliferation until the 
repair is completed. This involves activation of specific cell cycle checkpoint kinases 
(CHKs) that control the activity of cyclin dependent kinases (CDKs) known to regulate 
the cell cycle. Two key DNA damage signaling proteins, ataxia telangiectasia mutated 
kinase (ATM) and ataxia telangiectasia and RAD3-related kinase (ATR) phosphorylate 
various cell cycle checkpoint effectors (15). ATM and ATR function cooperatively in 
response to DSB and studies show that they are non-redundant in their physiological 
roles. DNA-PK is another essential kinase involved in NHEJ; however it is found to be 
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functionally redundant with ATM. Once dsDNA damage is sensed, it leads to activation 
of these repair proteins through MRN complex. Upon activation, they reach the site of 
damage and activate CHK. ATM phophorylates checkpoint kinase2 (CHK2) and Polo-
like kinase-1 (PLK1) and ATR phosphorylates claspin and again PLK1 (Figure 1.6). 
CHK arrests the cells in G2 phase by inactivation of CDKs (16, 17).  
Once repair has been completed, the checkpoint proteins are eliminated to allow the cell 
cycle to proceed. PLK1 promotes degradation of claspin and WEE1 protein kinases, that 
allows the G2-to-M transition by increasing CDK activity (18, 19). Figure 1.6 highlights 
the checkpoint kinases and cyclin-dependent kinases involved in the cell cycle 
checkpoint activation during repair. 
 
Figure 1.6: Cell cycle checkpoint activation by ATM and ATR. ATM and ATR activate 
check point kinases (CHK) and cell cycle proteins, which arrest the cell in different 
stages of cell cycle. Once the repair is completed successfully, the cell cycle proceeds by 
activation of cyclin dependent kinases (CDK). Or else, the cell is directed towards 




1.5 DNA Damage and Diseases 
DNA damage and defective repair proteins are found to be one of the key underlying 
causes for various diseases (20-23).  
Cancer: Chromosomal translocations arising due to errors in DNA repair pathway result 
in the formation of defective gene products, for example, fusion of proto-oncogene loci 
to antigen receptors arising from aberrant antigen receptor recombination (24). 
Mismatched DNA and mutated bases are found to cause colorectal and endometrial 
cancer (25, 26). Carcinogens are found to act by causing mutations, which lead to 
uncontrolled cell growth. High cell proliferation rate leads to replication stress and 
increased DNA damage, which directs the cells towards the apoptotic pathway. 
Mutational or epigenetic inactivation of the proteins involved in the apoptotic pathway 
leads to malignancies. Table 1.1 summarizes some of the malignancies caused by 
inactivation of repair proteins. 
Neurodegenerative diseases: DNA lesions in neuronal cells lead to diseases like ataxia, 
Alzheimer’s, Parkinson’s and Huntington’s. High concentration of reactive-oxygen-
species (ROS) in the brain arising due to high mitochondrial respiration, defective repair 
genes, and ageing lead to DNA damage in neurons. The damages are usually repaired 
through error-prone SSB or NER or NHEJ pathway and improper repair of defective 
genes increases the chances of neuronal cell death (23). Terminally differentiated 
neurons in adults are more severely affected by such damages due to the lack of 
replaceable neuronal cells. Ataxia is one such example where neurodegeneration occurs 
due to the defective ATM gene (27),(28)). (Table 1.1 and reference 5 give a detailed note 
on DNA damage based neurological disorders.)  
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Immune deficiencies and infertility: DNA repair proteins play an important role in 
genome rearrangements during immune system development. In particular, defects that 
affect the V (D) J recombination have been found to result in lymphoma or leukemia of 
B cells and T cells. Defects in NHEJ repair proteins are found to cause immune 
deficiencies. Ataxia Telangiectasia (AT) and Njimegen Breakage Syndrome (NBS) 
patients are found to suffer from severely impaired immunity due to defects in class 
switching (Table 1.1) (29). Damage to DNA repair elements is also found to affect 
human spermatogenesis leading to infertility. 
Table 1.2 lists a set the chemotherapeutics being developed to target components of the 
repair pathway for treatment of cancer. These agents have been successful to different 
extent. Their toxic side effects on healthy cells have prevented their usage for 
elimination of tumors. Prevalence of alternative repair pathways in tumor cells have 
been suggested to be one of major causes for limited effects of these chemotherapeutics. 
In short, DNA damage repair pathway components are extensively studied to understand 
the molecular basis of these diseases that arise due to their malfunctioning. 
Mre11/Rad50/Nbs1 complex is one such component in eukaryotes known to cause 





Table 1.1:Disease caused by defective DNA repair proteins. The table highlights the 
disease state, the corresponding phenotype or physiological effect and the defective 





Table 1.2: Chemotherapeutics available so far for treatment of cancer which potentially 
target the cell cycle proteins (Source: Bolderson E et al.(30) ). 
 
1.6 Mre11/Rad50/Nbs1 (MRN) Complex  
MRN complex is the first responder of the dsDNA damage response pathway. It 
activates ATM and ATR kinases which subsequently recruit the cell cycle check point 
kinases. Figure 1.7 depicts the role of MRN in multiple DNA repair pathways. MRN 




Figure 1.7: Role of MRN in DNA repair and cell cycle control. Mre11 leads to 
activation of several downstream pathways depending on the nature of damage. It has 
been found to play an important role in homologous recombination (HR), non-
homologous end joining (NHEJ) and activation of apoptotic pathway. This figure 
emphasizes key role of MRN complex in maintaining cellular stability. (Source: 
Stracker. TH. et al. 2011 (31)) 
 
Clinical significance of MRN complex: Mutations in Mre11 is found to cause 
neurological diseases that phenotypically match ataxia telangiectasia (AT) and is hence 
referred to as ataxia telangiectasia like disorder (ATLD) while mutation in Nbs1 causes 
Nijmegen breakage syndrome (NBS) (28). AT is characterized by muscle hypotonia, 
truncal swaying, abnormality in eye movement, cerebellar dysfunction, inability to sense 
vibration, reduction in sensory conduction velocity, and axonal degeneration of 
peripheral nerves (28). Mre11 mutation is found to be hypomorphic, which leads to 
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partial loss of function of the MR complex. Patients with this mutation do not have 
telangiectasia. However, they develop ataxia-like phenotype with a slower onset of 
neuronal degeneration. Mre11 inactivation mutations are also found to cause colorectal 
cancer (26, 32). Mutation in NBS gene leads to formation of N-terminal truncated protein. 
The N-terminal of Nbs is known to be essential for interaction with Mre11 and Rad50 
for subsequent activation of the ATM kinase. This truncation is found to cause 
microcephaly with occasional medulloblastoma brain tumors. Mutations in Rad50 gene 
have been reported to cause NBS-like disorder with increased radiation sensitivity and 
immunodeficiency (33, 34).   
Structure and function: MR complex consists of two components: Mre11, a nuclease, 
and Rad50, an ATPase which drives the nuclease. Mre11 provides ATP-independent 
ssDNA (linear and circular) endonuclease activity and, in the presence of Rad50 and 
Mn
2+
, it acts as an ATP-dependent 3’ to 5’ dsDNA (linear) exonuclease (35-40). Mre11 is 
composed of three domains: nuclease domain (ND), capping domain (CD) and C-
terminal Rad50 binding domain (RBD or CTD) (41-43) (Figure 1.8) . The highly 
conserved ND harbors six phophodiesterase motifs while the variable CD determines the 
nature of DNA processed by the complex (42, 43). . Dimerization of Mre11 enables DSB 
repair to take place by tethering the dimer to two DNA ends and bridging them in a linear 







A. Mre11 domain arrangement 
 
 
B. Structural representation        
    
                   
Figure1.8: Domain arrangement of Mre11 proteins: (a) The three domains are 
highlighted in box form and the flexible linker as the dotted line. The green segments 
within the nuclease domain box indicate the phophodiesterase motifs. (b) Structural 
presentation of the domains in Mre11 (Pink). The nuclease motifs harboring the active 
site are highlighted in green which occur at the loop segments. 
Rad50 belongs to the ABC-ATPase superfamily with DNA binding activity (45). The N- 
and C-terminal domains of Rad50 contain the ATP binding Walker motifs; Walker A and 
B, respectively. These two nucleotide-binding domains (NBD) are separated by a long, 
flexible coiled-coil segment which controls the tethering of DNA strands during repair 
(Figure 1.9A) (38, 46). The length of the coiled-coil segment varies from 200-to-700 















      
    
Figure 1.9: Domain arrangement of Rad50 proteins: (a) Domain arrangement of Rad50. 
(b) Structural presentation of the domains in Mre11 (Pink). Motifs and domains are 
highlighted in the respective colors shown in the block diagram (a). (c) MR with 
truncated Mre11 bound to AMP-PNP from Pyrococcus furiosus(PDB id: 3QKU). 
(d)Overlap of free PfRad50 and AMP-PNP bound PfRad50, highlighting the rotation of 








B. Structural representation of Rad50 domains C. AMP-PNP-bound PfRad50  
D. Overlap of AMP-PNP-bound 
and unbound PfRad50 
N-Lobe C-Lobe  
 18 
 
A conserved zinc-finger motif located at the center of this segment mediates dimerization 
of two MR complexes during sister chromatid bridging (Figure 1.9A and 1.10A) (46, 47). 
The N- and C-domain, also referred to as lobe I and II, house the conserved P, Q, D and 
H loops and a characteristic signature motif of the Rad50 family (48) (Figure 1A and 
1.9B). Each of these loops aid in conformational changes occurring in the Rad50 dimer 
post ATP binding. The coiled-coil domain interacts with Mre11 and allows tethering of 
homologous template.  
ATP molecules are held by the signature motif of one and the Walker A motif of another 
monomer (Figure 1.9C). ATP binding leads to conformational changes across the 
ATPase domain and the coiled-coil domain (Figure 1.9D). This conformational change is 
linked to unwinding of DNA substrate, which enables Mre11 to process the substrate. 
Crystal structures of PfRad50 reveal that ATP binding at the dimer interface leads to ~30º 






Figure 1.10: A. Molecular arrangement of MRN complex, a. Assembly of 
Mre11/Rad50/Nbs on the DNA substrate. Rad50 functions as a dimer and hence harbors 
two Mre11 interaction sites. The N and C domains of Rad50 are arranged in an 
antiparallel fashion b. AFM image of MR complex in DNA free and bound state. The 
images highlight the different orientations of the coiled-coil segment (Source: Stracker. 
TH. et al. 2011 (31)) B. Comparison of length of coiled-coil segment in different species. 
(courtesy: Scott Nelson) 
 
MR complex structure: Several Mre11 and Rad50 structures have been reported recently, 
but only two of these are of the MR complex. These were the free MR complex structure 
from Thermotoga maritima (TmMR) and ATPγS bound structure from Methanococcus 
jannaschii (MjMR) (Figure 1.11A,B) (42, 43). These complex structures revealed that 
MR is functionally a heterotetramer and the proteins share two interfaces: one across the 
RBD of Mre11 and coiled-coil segment of Rad50, and another across the CD of Mre11 
and lobe II of Rad50 (42, 43) (Figure 1.11). The CD of Mre11 is connected through a 
long unstructured segment to the RBD. Both CD and ND domains were found to be 
essential for Mre11 nuclease activity (42). The free TmMR crystal structure revealed that 
in the absence of ATP, the complex exists in an open conformation with the Rad50 
monomers seperated from each other (Figure 1.11A and 1.12A) (42). SAXS studies 
revealed that, upon ATPγS binding, the TmMR complex adopts a compact conformation 




bound MjMR and AMP-PNP-bound Pyrococcus furiosus MR complex (PfMR)  
supported this observation (Figure 1.11B, 1.9C) (43, 49). 
Based on the structural and biochemical data on MR from different species, multiple 
models of DNA repair by the complex have been proposed (Figure 1.12). These models 
corroborate the effect of ATP on MR complex. In the absence of ATP, the complex 
remains in the open loading form or the substrate accessible form where the separation of 
Rad50 monomers opens up the Mre11 nuclease site accessible. This is referred to as the 
open clamp mode (Figure 1.12). Binding of ATP leads to dimerization of the Rad50 
NBDs which decreases the accessibility to the Mre11 nuclease site. This state is referred 
to as the closed clamp mode.  
However, the models proposed to date differ in the proposed orientation of Rad50 NBDs 
with respect to the Mre11 domains. In the PfMR model constructed based on SAXS data, 
Mre11 ND and CD were proposed to be away from the nucleotide-binding region of 
Rad50 (50). On the other hand, the TmMR and MjMR structures show the presence of an 
interface between CD and NBD of Rad50 and hence in these models the NBDs of Rad50 
are oriented in an opposite fashion when compared to PfMR model (Figure 1.12B) (42, 
43, 49).  
Further, MjMR crystal structure and mutational studies indicated two possible 
orientations of Rad50 NBD with respect to Mre11 ND in the non-ATP-bound form which 








a. TmMR (Free form) 
         
b. MjMR (ATPγS bound form)                                    
Figure 1.11 Crystal structures of MR reported: (a) MR complex from Thermotoga 































       
 





Figure 1.12: Proposed models of MR complex from different species. Pink: Mre11 
domains. Blue: Rad50 domains. Mre11 nuclease domain (   ), capping domain (     ), 
linker region (    ), RBD (      ), n-terminal domain (     ), c-terminal domain (    ), coiled-
coil segment (      ,        ). ATP/AMP-PNP/ATPγS(   ). (a) TmMR model (ref) (b) PfMR 
model (ref) (c) Two models of MjMR model (ref). The models highlight the orientation 
of the different domains in the free complex (left) and AMP-PNP bound complex (right). 
Mre11-Rad50 /DNA binding mode Mre11-Rad50-AMP-PNP 
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1.7 SCOPE OF THIS STUDY 
Several structural models have been put forth to describe how the MR proteins function, 
yet ambiguity in the orchestration of DNA repair by the MR complex remains. Presence 
of multiple models for functioning of MR proteins underscores the dynamic nature of 
these proteins in solution. This emphasized the need to study the time-course behavior of 
MR proteins. Therefore, we chose to conduct a detailed in vitro biophysical 
characterization of the solution behavior of the MR proteins in free and complex form 
under different conditions over time. For our study, we used the MR complex from 
bacteriophage T4 also known as gp46/47 which was recently characterized (51). The 
reasons for choosing T4 proteins have been highlighted in section 1.8. We explored the 
behavior of T4MR proteins using a heavy isotope labeling technique — amide deuterium 
exchange followed by mass spectrometry (HDXMS) (52). A detailed description about 
this technique is highlighted in section 1.9. HDXMS serves as an ideal technique to 
capture the short time-scale conformational changes occurring in the order of minutes 
within the system which are critical for the allosteric regulation of Mre11 nuclease 
activity. Using the available database of crystal structures of the MR proteins, we studied 
the deuteration pattern of proteins in the unassociated form, in complex form, and AMP-
PNP-bound form. This study enabled us to identify the most probable orientation of the 
T4Rad50 and T4Mre11 domains and the allosteric regulation sites in T4Mre11 and 
T4Rad50. Some of these sites have been shown to affect the nuclease activity of Mre11 








In vitro biophysical characterization of the solution behavior of the T4 




















1.8 T4 Bacteriophage MR complex 
T4 is an obligate parasite of Escherichia Coli and one of the key model organisms 
studied for over 60 years to understand fundamental processes in molecular biology. It is 
composed of an icosahedral-shaped head harboring the genetic material required for its 
replication, followed by a neck segment with collar and a hollow tail segment surrounded 
by a contractile sheath, which allows it to attach to host cell for transfer of the genetic 
material. 
 
Figure 1.13: T4 Phage structural organization (53). 
 
The T4 genome is composed of 168.9 kbp long linear double-stranded DNA, which 
codes for over 300 gene products. The DNA sequence was found to be redundant at the 
termini, leading to increase in length to about 172 kb, which is known to be a replication 
strategy to protect DNA during replication (54). It is also the first virus found to contain 
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introns in its genome, which was one of the key indicators of its ancestral relationship to 
eukaryotes. 
T4 and T2 phage were among the first model organisms used to demonstrate existence of 
DNA as a genetic material, triplet genetic code, discovery of mRNA, importance of 
recombination in DNA replication, DNA repair mechanisms, restriction and modification 
of DNA, splicing of introns, and many more fundamental biological concepts. Analysis 
of the T4 nucleotide-synthesizing complex, the replisome, and recombination complexes 
has given us insights into macromolecular interactions and how biological “molecular 
machines” function (53).  
Ease of production and isolation of T4 proteins in the 1970s allowed study of duplex 
DNA replication mechanisms and the proteins involved. Later studies on eukaryotic and 
bacterial replication systems were found to correspond highly with what was known from 
the T4 phage system. Berstein et al. carried out an extensive genetic homology study of 
the T4 genes with the bacterial and eukaryotic counterparts and showed that they share 
equal ancestry with eukaryotes and bacteria. Table 1.3 lists some of the T4 genes 
homologous to bacterial and eukaryotic genes (55). Our study focuses on the gene 
products 46 and 47 (highlighted in Table 1.3), which are homologues of human Rad50 
and Mre11 proteins, respectively. T4Rad50 and Mre11 share 38% and 28% sequence 
identity with corresponding human homologues. gp46 and 47 are among 130 
uncharacterized genes from T4 phage genome. All the recombination-dependent DNA 
replication enzymes and proteins in T4 phage have been characterized, except gp46/gp47 




As highlighted in earlier sections, extensive biochemical and structural studies have been 
carried out on archae and bacterial counterparts of Mre11 and Rad50 proteins. Crystal 
structures of MR complexes from Pyrococcus furiosus (thermophilic archae), 
Thermotoga maritima (thermophilic bacteria) and Methanococcus jannaschii 
(hyperthermophilic archae) have been published (41-43). Biochemical characterization of 
the T4MR proteins revealed that it behaves in a similar fashion as other MR proteins (53). 
However, there have been no structural or biophysical studies carried out yet on the 
T4MR proteins 
Ease of production: T4Rad50 coiled-coil segment is composed of only 200 residues as 
compared to the humanRad50, which is composed of 900 residues. Thus, functional 
heterotetrameric T4MR complex, with a molecular weight of 200kDa, is one of the 
smallest across the three kingdoms (Figure 1.10B). T4Mre11 and Rad50 protein yields 
are much higher (10-25mgs from 1l of E.Coli culture) when compared to yeast and 
human MR complex where the yield typically ranges in microgram quantities (51, 56, 57). 
Human Rad50, which is co-expressed with Mre11 in insect cell lines, is found to be 
difficult to express due to the length and flexibility of the coiled-coil segment. However, 
T4Rad50 owing to a smaller size is found to be comparatively more stable and easier to 









Table 1.3: T4 gene segments homologous to eukaryotes and bacteria. (Source: Bernstein 




1.9 Hydrogen/Deuterium Exchange followed by Mass Spectrometry (H/DX-MS) 
 
 
Figure 1.14: Exchangeable hydrogens in a protein. Red: Amide hydrogens with slow 
exchange rate, Green: covalently attached hydrogens, which do not exchange, Blue: side 
chain hydrogens, which have high exchange rate and hence, are undetectable. (Source: 
www.hxms.com) 
 
Amide hydrogen/deuterium exchange mass spectrometry is a sensitive technique used to 
study protein-protein, protein-ligand interactions, protein folding and denaturation in 
solution (52, 58, 59). Proteins constantly undergo exchange of hydrogens with the 
solvent. There are two different kinds of hydrogen atoms available for exchange in a 
polypeptide chain – main chain amide hydrogens and side chain hydrogens. The main 
chain hydrogens, which are covalently linked to carbon atoms do not exchange while 
side chain hydrogens have a high back exchange rate and hence are not monitored 
during experiments (Figure1.14). 
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The exchange kinetics of a protein is a function of its structure, pH of the solution, and 
the adjacent side chain groups of an exchangeable amide. The exchange kinetics is 
monitored by diluting concentrated protein solution in D2O, which leads to replacement 
of amide hydrogen during solvent exchange by deuterium, a heavier isotope. The proton 




(base), D2O or buffer ions. At 
physiological pH, at which the proteins function, it is catalyzed by OD (59).   
 A-H + OD
−
       A
−





                  A-D + D2O 
This exchange reaction is quenched by lowering the pH to 2.5 and temperature to 4ºC. 
The deuterated sample is further subjected to digestion by pepsin (which functions at low 
pH). The pepsin-generated peptide fragments are resolved using reversed-phase HPLC 
and further analyzed using ESI-MS (electrospray ionization mass spectrometry).   
The number of deuterium incorporated is calculated by the given equation (58): 
      
Where D is the deuterons incorporated after correcting for those lost during the digestion 
and separation, N is the number of exchangeable amides (total no. of amides minus N 
terminal and prolines if any), m0%, m100% and m refer to average of the molecular masses 
(centroid of the MS peak) of the non-deuterated, completely-deuterated control samples 
and sample at time point t, respectively (58). The corrected deuterons number is then 




 Figure 1.15: Workflow for HDMS (Adapted from Busenlehner LS et al.  (58) ). 
 
Figure 1.16: Deuterium incorporation quantification. i. Steps involved in the HDX-MS 
experiments. ii. Detailed picture of centroid calculation. As shown in the table, centroid 




calculate the relative increase in deuteration levels (B). The deuterium levels are then 
plotted vs time (C) (Adapted from Zheng X et al., 2008 (60) ). 
The solvent accessibility of different segments of a protein differs according to its tertiary 
structure. Residues occurring in the compactly folded hydrophobic core would be less 
solvent accessible compared to those present on the surface, which gives rise to different 
exchange patterns in peptide spanning the two regions. This difference in exchange rate 
serves as a tool to monitor conformational changes in a protein when its environment 
changes (58, 59).  
Regional unfolding and refolding events in solution contribute to the intrinsic exchange 
rate of an amide. Figure 1.17 shows the Linderstrøm-Lang model for deuterium exchange 
kinetics in solution. There are two kinds of kinetics described by the model: EX1 and 
EX2. In EX1 kinetics, the rate of local folding (kc) is faster than rate of intrinsic amide 
exchange rate (ki), hence rate of exchange (kex) depends on intrinsic exchange rate and 
equilibrium constant between open and closed state (ko/kc). In EX2 kinetics, rate of 
intrinsic exchange is faster than rate of folding and hence rate of exchange (kex) is 
determined by rate of opening (ko) (refer to equation in Figure 1.17). EX2 is characterized 
by random distribution of amides while peptides showing EX1 are characterized by 
regions, which either get completely or not at all deuterated, thus generating a bimodal 
isotopic pattern in the mass spectra (58, 60).  
Hydrogen bonding, solvent accessibility, and backbone flexibility affect the kinetics of 
hydrogen exchange. Comparison of the exchange profiles of protein fragments in native 
state and the ligand-bound state provides insight into local and global conformational 




Figure 1.17: A. Linderstrøm-Lang model for deuterium exchange for proteins at neutral 
pH subjected to fluctuations (58). kex –experimental rate constant for exchange, ki- 
intrinsic amide exchange rate in the fully unfolded state, ko -rate of opening and kc -rate of 
closing. B. The mass spectra profile for EX1 and EX2 kinetics (Adapted from Zheng X et 
al., 2008 (60)).  
 
Our study focuses on identifying the conformational changes occurring in Mre11 and 
Rad50 once the MR complex formation occurs and after AMP-PNP binds to the complex. 
The hydrogen exchange profiles of the free proteins, the complex, and AMP-PNP-bound 





















2.1 Cloning, protein expression and purification 
T4Mre11 cloned into pTYB1 plasmid for intein-assisted tag-free protein production 
(New England Biolabs, Ipswich, MA, U.S.A.) was obtained from Scott Nelson’s 
laboratory (51). C-terminal truncated T4Mre11: Mre11297 (1-297), Mre11321 (1-321), were 
prepared by amplifying and inserting respective sequences into pTYB1 (Figure 2.1). 
These truncations are designed based on the available PfMre11 crystal structure (PDB id: 







 were expressed in BL21 (DE3) (Invitrogen, 
Carlsbad, CA, U.S.A.). Cells were grown to an OD600 of 1.0 and expression was induced 
using 0.15 mM IPTG for 16 h at 18°C. Cells were harvested by centrifugation at 6,000 
rpm for 30 min, frozen at –80°C, and lysed in the Mre11 lysis buffer (20 mM Tris-HCl 
pH 7.8 and 1 mM EDTA) with 500 mM NaCl. After centrifugation at 12,000 rpm for 45 
min, the cell-free extract was loaded onto a chitin column and washed overnight with the 
Mre11 lysis buffer with 1 M NaCl. Following the wash, on-column intein cleavage and 
T4 Mre11 release was performed by quickly flushing the column with cleavage buffer 
containing 75 mM β-mercaptoethanol and incubating the column at 4°C for 24 h. After 
cleavage, T4Mre11 was eluted from the column using the Mre11 lysis buffer. The eluted 
proteins were dialyzed into buffer A (20 mM Tris-HCl pH 7.5, 1 mM DTT, 1 mM 
EDTA, 10% glycerol) for anion exchange chromatography using Hitrap Q XL (GE 
Healthcare, Piscataway, NJ, U.S.A.). Full-length and truncated Mre11 were eluted at 27% 
buffer B (buffer A with 1 M NaCl). The eluted Mre11 fractions were further purified by 
gel-filtration using Superdex 200 10/300 GL (GE Healthcare) with a running buffer 




Figure 2.1: Mre11 sequence. Deletion of residues in red corresponds to Mre11
321
 and 
deletion of both blue and red residues corresponds to Mre11
297
 
T4Rad50 cloned in pTYB1 vector was found produce unstable protein. Hence, it was re-
cloned into pET28 vector with N-terminal his-tag using EcorI and NdeI restriction sites. 
For this purpose, the Nde I site within the T4Rad50 gene was mutated from CATATG to 
CATAAG. This was done in two set of reactions using Rad50_pET_F1 and 
Rad50_pET_R2 primers for one reaction and Rad50_pET_F2 + Rad50_pET_R1 as 
primers for the other (sequence listed in table 2.1). Two fragments hence obtained were 
digested, purified, and mixture was used as template for amplification using 
Rad50_pET_F1 and Rad50_pET_R1 to generate the entire Rad50 coding fragment with 
mutated Nde1 site. This fragment was further cloned into Nde I/ EcoR I of pET28 vector 
using the standard protocol. 
 
Table 2.1: Primer sequences for cloning T4Rad50 into pET28 vector. 
BL21 (DE3) cells carrying Rad50 gene were grown to an OD600 of 0.5 and induced using 
0.15 mM IPTG for 16 h at 18°C. Cells were harvested by centrifugation at 6,000 rpm for 
297 321 339 
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30min, frozen at –80°C, and lysed in the Rad50 lysis buffer (50 mM sodium phosphate 
pH 7.4, 300 mM NaCl) with 10 mM imidazole and 10% glycerol. After centrifugation at 
12,000 rpm for 45 min, the cell-free extract was loaded onto a cobalt column (Thermo 
Scientific) and washed with the Rad50 lysis buffer. T4Rad50 was eluted using lysis 
buffer containing 150 mM imidazole, and further purified by gel-filtration (Superdex 200 
10/300 GL) in buffer containing 20 mM Tris-HCl, pH 7.2, 150 mM NaCl, 1 mM EDTA. 
For complex preparation, purified Mre11 and Rad50 were mixed at a 2:1 molar ratio, and 
the mixture was purified using gel filtration in similar fashion as Rad50. For the complex 
with AMP-PNP sample, the protein was gel filtration purified into buffer containing 20 
mM Tris-HCl pH 7.2, 5 mM MgCl2, 1 mM MnCl2, 5% glycerol. The protein after 
purification was concentrated to desired level and then incubated with 1 mM AMP-PNP 
for 30 min before performing the deuterium exchange experiments. 
 
2.2 Circular Dichroism 
Full length Mre11 and its truncated versions were concentrated to 100 μM in 20 mM 
sodium phosphate pH 7.5, 0.1 mM EDTA. The CD spectrum was measured using a Jasco 
J810 spectropolarimeter equipped with a Peltier temperature controller and a quartz cell 
of 0.1 cm path length. The spectrum was recorded at a bandwidth of 0.1nm and 
acquisition time of 50 nm/sec. Three scans were performed at wavelength ranging from 
190 nm to 260 nm at 25° C. The sample spectra were corrected by subtracting the buffer 




2.3 Nuclease Assay 
Mre11 nuclease assay was performed in 20 mM Tris-HCl pH 8.0, 50 mM NaCl, 1 mM 
DTT, 5 mM MgCl2, 1 mM MnCl2, 2 mM ATP at 37°C. Mre11, the truncated protein 
were incubated with Rad50 and dsDNA substrate (5’CTT ACT GTG TCA TCT CTT 
ACT GTG TCA TCT 3’) at a concentration of 0.3 μM in separate tubes. Samples were 
collected at 0 min, 10 min, 30 min, 8 h, and 23 h, and loaded onto 20% TBE-PAGE gel 
and stained using gel green for analysis. 
2.4 Isothermal Titration Calorimetry (ITC) 
Microcal VP-ITC (GE Healthcare) was used to estimate the KD and stoichiometry for the 
interaction of Rad50 and T4Mre11 variants mentioned above using standard procedure as 
described earlier (50, 62-66). Titrations were performed with the Mre11 proteins and 
Rad50 at 25°C in 20 mM Tris-HCl pH7.2, 150 mM NaCl, 1mM EDTA at 25ºC. The 
proteins were dialyzed into the buffer at 4ºC before titrations to ensure that the heat 
change due to buffers is minimized. The proteins were then concentrated using Vivaspin 
concentrators (GE Healthcare) and degassed under vacuum by gentle stirring for five 
minutes just before use. T4Mre11 proteins
 
(65 µM in the syringe) were titrated in 10 µl 
increments against Rad50 (6 µM in the well) with a time interval of 270s. The baseline of 
the isotherm was smoothened and baring the first peak, other peaks were integrated to 
obtain the heat change. The stoichiometry (N), the dissociation constant (KD) and the 
enthalpy ΔH were calculated using ORIGINTM software package provided by Microcal 




2.5 Atomic Force Microscopy 
The linear PhiX174 DNA was used for AFM analysis, which was obtained by digesting 
PhiX174 plasmid (New England Biolabs Inc., Ipswich, MA, U.S.A) with restriction 
enzyme StuI (New England Biolabs Inc., Ipswich, MA, U.S.A). The fragment was 
further purified using QIAquick PCR purification kit (QIAGEN, CA, U.S.A). The DNA 
sample was prepared in imaging buffer (20 mM Tris-HCl, 10 mM MgCl2, 25 mM NaCl, 
pH 8.0) at concentration of 0.1ng/µl. Mre11–Rad50–DNA mixtures of certain 
DNA/protein ratios was prepared by incubating 2 ng linear PhiX174 DNA with 
corresponding amount of purified T4Mre11 and Rad50 complex in a final volume of 20 
µl at 37°C for 20 min. ATP (1 mM) or ATPγS (1 mM ) was added together with DNA 
and protein prior to incubation for Mre11–Rad50–DNA mixtures in the presence of ATP 
or ATPγS. The mixtures were then diluted 10-fold in imaging buffer, and 50 µl portion 
was deposited on freshly cleaved mica. After about 12 min, mica was washed with 
deionised water, and dried with a stream of compressed nitrogen gas. Samples were 
imaged with a Molecular Imaging atomic force microscope (Agilent Technologies, 
Santa Clara, CA, U.S.A) operated in AAC mode in air at room temperature. Silicon 
AFM probes, BudgetSensors Tap 300 (Innovative Solutions Bulgaria Ltd., Sofia, 
Bulgaria) were used. AFM images were processed only by flattening to remove the 
background slop using the Gwyddion software. 
2.6 Hydrogen/Deuterium Exchange followed by Mass Spectrometry (H/DX–MS) 
Purified T4Mre11, T4Rad50 and complex were concentrated to 35, 25 and 50 µM, 
respectively, using Vivaspin
TM
 concentrator (Sartorius, Goettingen, Germany) and 
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concentrations were estimated using UV spectrophotometer (280nm). Four samples were 
prepared in respective sample buffers: 
a. 35 µM of T4Mre11 in 20 mM Tris-HCl pH 7.5, 0.1 mM EDTA 
b. 25 µM of T4Rad50 in 20 mM Tris-HCl pH 7.2, 150 mM NaCl, 1mM EDTA 
c. 5 µM T4MR complex without AMP-PNP in 20 mM Tris-HCl pH 7.2, 150 mM NaCl,  
    1mM EDTA. 
d. 50 µM complex with AMP-PNP in 20 mM Tris-HCl pH 7.2, 150 mM NaCl, 1 mM    
 MnCl2, 5 mM MgCl2. The complex was incubated with 1mM of AMP-PNP for 30mins    
 before performing the experiment.  
Preliminary runs were carried out to determine the optimum concentration required for 
each sample. 2 µl of the samples were incubated in 18 µl respective sample buffers 
prepared in D2O (final concentration-90%) for various time intervals (0.5, 1, 2, 5 and 
10min) at 20ºC. The exchange reaction was quenched using 30 µl of prechilled 0.1% 
TFA to lower the pHread to 2.5. 50 µl of the quenched sample was injected into nano-
UPLC sample manager (Waters, Milford, MA, USA) maintained at 4°C, wherein, the 
sample was allowed to pass through a pepsin column (Porozyme, ABI, Foster City, CA) 
using 0.05% formic acid as solvent at a flow rate of 100 µl/min. The digested peptides 
were then trapped in a 2.1 x 5 mm C18 column (ACQUITY BEH C18 VanGuard Pre-
column, 1.7 μm, Waters, Milford, MA), eluted using a gradient of 8-40% acetonitrile 
containing 0.1% formic acid at a flow rate of 40 µl/min using nano ACQUITY Binary 
Solvent Manager (Waters, Milford, MA). The eluted peptides were further resolved using 
a reversed–phase, 1.0 x 100 mm, C18 column (ACQUITY UPLC BEH, Waters, Milford, 
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MA, USA). This was followed by mass spectrometric analysis using SYNAPT HDMS 
(Waters, Manchester, UK) in MS
E
 mode (67). Samples were tested for each time point in 
duplicates. The instrument was continuously calibrated with Glu-fibrinogen peptide 
(GFP) at 100fmol/µl. 
Using the MS
E 
data, a peptide list was generated based on the undeuterated sample using 
ProteinLynx Global Server (PLGS 2.4 beta test version, Waters, Milford, MA, USA) (68). 
The peptides, which appeared in duplicate sets were selected and further analyzed using 
HDX browser (prototype by Waters, Milford). Time point data for each peptide was 
collated on HDX browser, extracted into a format compatible for analysis using HX 
express program to quantify the deuterons incorporated (69, 70). Each peptide was 
manually analyzed to eliminate peaks with poor signal to noise ratio. Control experiments 
were carried out to estimate the back exchange rate wherein the sample was incubated in 
D2O for 24 hours. Peptides from highly solvent exchangeable region, which underwent 
100% exchange at 10 min time point, were chosen. Average of the back exchange rate 
seen in these peptides was estimated to be 32.7% (71, 72). This exchange rate was found 
to be consistent in multiple rounds of experiments. Hence, all the centroid values for the 
peptides were corrected by a multiplication factor of 1.49.  The deuteron numbers were 
then plotted against time based on one-phase association model using PRISM
TM 




















3.1 Protein Expression and Purification 
Figure 3.1 highlights the purity of the Mre11
WT 
fractions obtained from intein-tag 
purification. After incubation with the cleavage buffer, beads indicated the presence of 
intein, fusion protein and Mre11 (lane 6 and 7). The elution was allowed pass through 
another clean chitin column, which allowed us to get rid of the fusion protein and intein 
(lane 8). The yield for recombinant wild type and truncated Mre11 proteins were 






 Intein tag purification 1: lysate; 2, 3: flow through; 4, 5: 
cleavage buffer through the column; 6, 7:  the first two chitin column beads; 8: the 
second chitin column beads (to remove fusion protein and intein); 9, 10: elutions; 11, 12: 









                                
Figure 3.2: T4Mre11
WT 
Purification profiles. A. Anion exchange profile for T4Mre11
WT
  
B. Gel filtration profile T4Mre11
WT




    
Figure 3.3: T4Rad50 purification: A: Gel filtration profile and B: the corresponding peak 






Intein-tag T4Rad50, which initially gave us poor yields and unstable protein was found to 
give significantly pure protein and higher yields after cloning into pET28 vector with his-
tag. The yield for his-tag T4Rad50 was found to be ~30mg/L of culture. 
 
 
Figure 3.4: T4MR complex purification profile. A: Gel filtration peak of the complex 
and B: SDS-gel. The complex gel filtration revealed three peaks: peak1 and 2 were found 
to contain the complex; peak3 corresponds to the excess Mre11 protein. 
 
The gel filtration purification of T4MR complex revealed presence of three peaks. Based 
on analysis using SDS-PAGE, peak 1 and 2 were both found to contain the complex and 
peak 3 was found to contain excess Mre11 (Figure 3.4). Peak1 and 2 were further 
analyzed using analytical ultra centrifugation experiments (AUC) (refer to appendix B). 
Peak 2 was found to correspond to a molecular weight of 189kDa indicating a 
stoichiometric ratio of 2:2 of the proteins when in complex (Mre11-39kDa, rad50-
62kDa). Peak1 was found to give an anomalous molecular weight and hence eliminated 
from further analysis. Addition of ATP to the complex obtained from peak 2 did not 











3.2 C-terminal domain of T4Mre11 is essential for its nuclease activity 
We sought to first identify the minimal fragment of T4Mre11 required for MR 





. The wild type Mre11 (Mre11
WT
) is 339 residues long. 







 digested the substrate in ten minutes but the 
truncated Mre11s failed to do so even after 8 hours (Figure 3.5). Circular dichroism 
results indicated that the lack of activity was not due to loss of structure (Figure 3.7). 
Subsequently, binding studies were carried out to test if the truncated proteins were able 
to bind T4Rad50 using isothermal titration calorimetry (ITC). The binding isotherms 
confirmed that the activity of truncated proteins was lost due to their inability to bind 
Rad50 (Figure 3.7). These observations highlighted that the C-terminal of T4Mre11 was 
necessary for binding Rad50 and the nuclease activity. This requirement for the Mre11 C-
terminal segment for the MR complex formation was also observed in other MR protein 
complexes  (42, 50). 











truncation constructs . dsDNA (30mer) incubated with Mre11 and activity was arrested at 
different time points. The samples were loaded onto TBE gel and stained using gel green for 
visualization. DNA substrate incubated with T4 Mre11
(WT) 
 for 0min , 10min , 30min, 8h, 23h 
(Lanes 1-5), T4 Mre11
(321)
 0min, 10min, 30min, 8h, 23h (Lanes 6-10)  T4Mre11
(297)
 0min, 
10min, 30min, 8h, 23h (Lanes 11-15).  






WT   T4Mre11321   T4Mre11





Figure 3.6: Circular Dichroism spectra of the Mre11 truncated proteins.  Mre11WT(♦),Mre11 
321
(●) and  Mre11297(▲) 
B. 
 






(321). For all the constructs, 65 μM of Mre11 was titrated against 
6 μM of Rad50. The truncation proteins failed to interact with Rad50. The Mre11 WT was 









3.3 Solution behavior of T4MR complex using HDXMS 
Overview  
Deuterium exchange experiments were carried out on four samples: T4Mre11, T4Rad50, 
T4MR complex, AMP-PNP-bound T4MR complex. AMP-PNP was used to study the 
ATP induced conformational changes occurring in the MR complex. For T4Mre11, 24 
common peptide fragments covering more than 90% of the sequence was analyzed 
(Appendix D). 33 common peptide fragments covering 91% of the Rad50 sequences 
were analyzed (Appendix E). The exchange percentage was calculated by dividing the 
average number of deuterons exchanged at each time point for each peptide with the 
number of exchangeable amides for the given peptide (% deuteration = 100* D/N). The 
percentage exchange for all the peptides was then tabulated to plot the heat map using the 
HXMS online tool (74). The exchange rate for both the proteins are shown using a color 
scheme in Figure 3.8. Violet and brown represent the lowest (10%) and the highest 
exchange rates (>90%), respectively. Sequence alignment of T4Mre11/Rad50 with 
Mre11/Rad50 from other species is shown in Appendix C.The deuterium exchange 
profiles of the peptide fragments were mapped onto a model structure which was built 
using MODELLER with MjMR (PDB id: 3AV0) as a template (75) (Figure 3.9).The 
pattern of exchange of the T4MR complex in comparison to free proteins and the AMP-
PNP-bound T4MR complex as compared to the free complex are shown in Figure 3.9A 
and 3.9B, respectively. This section discusses the deuterium exchange profile of the 
peptide fragments, which show difference in free, complex, and AMP-PNP bound forms. 
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Figure 3.8 A : Heat Map of T4Mre11. The three bar represent the exchange profile for 
the peptide in Free Mre11, MR complex and MR complex with AMP-PNP. Individual 
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Figure 3.8 B: Heat Map of T4Rad50. The three bar represent the exchange profile for the 
peptide in Free Rad50, MR complex and MR complex with AMP-PNP. Individual bars 
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Figure 3.9: Amide exchange pattern for the MR complex. The structure of the T4MR 
heterotetramer was generated based on MjMR complex bound to ATPγS (PDB ID: 
3AV0) as template using MODELLER.(a) Overall amide exchange pattern of the Mre11 
and Rad50 segments after complex formation in comparison to the apo proteins. BLUE: 
represents peptide segments showing decrease in amide exchange RED: Increase in 
amide exchange. (b) Amide exchange pattern of MR-AMP-PNP complex when 
compared to the MR complex. (c)  Binding of AMP-PNP at Rad50 dimer interface. The 
nucleotide binding motifs of Rad50 (RED) and nuclease motifs Mre11 (BLUE) show 











3.3.1 Formation of the T4MR complex — A conformationally stable state 
The amide exchange levels of the segments of T4Rad50 and T4Mre11 segments forming 
the complex interface were found to be lower in comparison to free protein state, 
especially, the NBD of T4Rad50 and ND of T4Mre11 (Figure 3.9A). The peptide 
fragments encompassing the characteristic Rad50 motifs, including — Walker A (three 
deuterons), Q loop (one deuteron), D loop (one deuton) and the H loop (one deuteron), 
showed corresponding decreases in deuteron uptake (Figure 3.9A). The decrease of 
deuterons in these T4Rad50 segments after MR complex formation suggested it is driven 
to a less solvent accessible closed dimer state. In T4Mre11, peptide fragments spanning 
the recognition loops harboring the active site residues for nuclease activity showed a 
decrease in deuteron uptake after complex formation and a further decrease post AMP-
PNP binding (Figure 3.9C, Appendix D, highlighted in yellow). This decrease suggested 
that the T4Rad50 NBDs infact lie close to T4Mre11 ND.  These observations were found 
to support the open state of MjMR model II wherein the Rad50 dimers occur close to 
each other and adjacent to the Mre11 nuclease domains (Figure 3.10, C.II), and not in the 
open Rad50 conformation or in the conformation where Mre11s sit away from the Rad50 
NBDs as seen other MR models (Figure 3.10) (42, 65). 
3.3.2 AMP-PNP captures the complex in an open transition state 
Subsequently, we compared the T4Rad50 amide exchange pattern as a free protein 
without AMP-PNP to Rad50 in complex and Rad50 in complex bound to AMP-PNP. It 
was interesting to observe that AMP-PNP binding increased the deuteron uptake of 






















      
 





Figure 3.10: Proposed models of MR complex from different species. Pink: Mre11 
domains. Blue: Rad50 domains. Mre11 nuclease domain (   ), capping domain (     ), 
linker region (    ), RBD (      ), n-terminal domain (     ), c-terminal domain (    ), coiled-
coil segment (      ,        ). ATP/AMP-PNP/ATPγS (   ). (a) TmMR model (42) (b) PfMR 
model (41) (c) Two models of MjMR model (43). The models highlight the orientation of 
the different domains in the free complex (left panel) and AMP-PNP bound form (right 
panel). 
Mre11-Rad50 /DNA binding mode Mre11-Rad50-AMP-PNP 
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Again, the peptide fragments covering the key motifs at the Rad50 dimer interface – 
signature motif (468–482), Walker A (27–46), Walker B (502–511), Q loop (133–148) 
and D loop (512–525) showed an average increase of two deuterons in each segment 
(Figure 3.9C). The increase, however, was not just restricted to the T4Rad50 dimer 
interface but in segments away from the interface, showing that Rad50 becomes 
conformationally more flexible (Figure 3.9B). Contrary to the T4Rad50 behavior, 
T4Mre11 showed further decrease in deuteration rate post AMP-PNP binding as 
compared to in the complex. Especially, peptide fragments covering the nuclease motifs, 
motif II (51–63), III (79–97), IV (161–174), V, (178–191), VI(195–217) (Figure 3.9C, 
Appendix D). Each of these segments showed at least one deuteron decrease in deuterium 
uptake. These deuteration profiles suggested that AMP-PNP held the Rad50 monomers 
away from each other in an open transient state but the Mre11 nuclease domains become 
less flexible and more solvent inaccessible. These observations were in agreement with 
AMP-PNP-bound models of MjMR and PfMR wherein the binding of AMP-PNP leads 
to opening of the Rad50 dimer and rotation of the coiled-coil segment. However, the 
orientation of Mre11 NDs in PfMR complex (Figure 3.10B) does not support the T4MR 
amide exchange data. These deuteration patterns suggested that Mre11 in fact adopts a 
more stable conformation for nuclease activity to proceed. 
3.3.3 Conformational changes across lobe II of T4Rad50 and T4Mre11 capping 
domain 
Signature motif of T4Rad50 has been previously implicated in allosteric activation of the 
complex (76).The amide exchange profile of lobe II loop (454–467) adjacent to signature 
motif showed difference upon AMP-PNP binding. It was interesting to observe that the 
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T4Mre11 capping domain segments (260– 272 and 282– 298) which lies close the Rad50 
loop also showed deuteration differences upon complex formation and ATP binding 
(Figure 3.11A). T4Rad50 loop (454–464) showed a single deuteron decrease after the 
MR complex formation and a deuteron increase after AMP-PNP binding. T4Mre11 
capping domain segment 260–272 showed a decrease of two deuterons after complex 
formation and an increase of two after AMP-PNP binding, giving a similar pattern to 
what was observed with the T4Rad50 loop described earlier (Figure 3.11C). Fragment 
282–298, on the other hand, showed an increase of more than two deuterons during the 
complex formation and a decrease of three after AMP-PNP binding (Figure 3.11D). 
Closer inspection of the amino acid sequence of in these segments (Mre11—260–272, 
282–298 and Rad50—454–464) on either proteins showed that the residues were 
oppositely charged suggesting a presence of ion-pair interaction similar to what has been 
observed in the MjMR complex. We speculate the involvement of the side chain of R460 
of T4Rad50 which lies adjacent to the signature motif, and the side chain of T268 and 
D288 and the main chain of K286 and I287 in the T4Mre11 capping domain in the 
Rad50-Mre11 interaction (Figure 3.11B). Mutation studies in this Mre11-Rad50 
interaction interface in the MjMR complex have been shown to affect the nuclease 
activity (65). These conformational changes in the capping domain segments of T4Mre11 
post AMP-PNP binding suggest that T4Mre11 capping segment could also share an 






    
 
 
Figure 3.11:  Allosteric relay at lobe II of T4Rad50 and capping domain of T4Mre11. (a) 
Cross sectional view of the lobe II loop of T4Rad50 and T4Mre11 capping domain 
interaction segment. The lobe II loop lies adjacent to the signature motif (green) bound to 
the ATP-γS.(b) Closer view of residues speculated to be involved in electrostatic 
interaction. R460 from T4Rad50 lies adjacent to the T268 and K286 from 
T4Mre11.(c)Time course of amide HDX (0.5-10mins) for peptide fragments 262-272 of 
Mre11 (m/z = 547.3, z = +2), (d) 282-298(m/z = 954.45, z = +3) and (e) Rad50 fragment 
454-468 (m/z= 851.4). The solid lines on the graphs denote the best fit of the data to a 
one-phase association non linear exponential curve fit (GraphPad Prism 5.0(San 
Diego,CA). 
Mre11 (262-274)













































































3.3.4 Conformational changes across the His loop of T4Rad50 and nuclease motif of 
T4Mre11 
MjMR complex structure had previously revealed an interaction between the nuclease 
domain of Mre11 and the His switch of Rad50 (65). T4MR deuterium exchange study 
identified a similar interaction. Binding of AMP-PNP was found to affect the deuteration 
pattern of a peptide fragment spanning the His loop (532–548, Figure 3.12A and D) of 
T4Rad50. This segment lies close to the Walker A (a T4Rad50 motif highlighted in 
green, Figure 3.12A) which along with the signature motif from the adjacent T4Rad50 
unit binds the second AMP-PNP molecule (magenta in Figure 3.12A) of the 
heterotetramer. Two peptide fragments spanning these two nuclease motifs: 51–63 (II) 
and 79–97 (III) showed differential deuteration patterns during the complex formation 
and after AMP-PNP binding. Motif II showed a consistent protection while motif III 
showed an increase (one deuteron) followed by a decrease in deuteron uptake levels 
(three deuterons) (Figure 3.12C and E).The His loop peptide fragment: 532–548, showed 
a decrease of close to two deuterons upon complex formation and one deuteron increase 
after AMP-PNP binding (Figure 3.12D). The difference in the deuteration pattern 
indicates that AMP-PNP binding to T4Rad50 could allosterically affect the nuclease 
activity of Mre11 through the His loop interaction. The possible residues involved in 
hydrogen bond interaction between the His loop and nuclease motifs are highlighted in 




    
                   
        
 
Figure 3.12: Allostery across the T4Rad50 His loop and T4Mre11 nuclease motif. (a) 
Cross sectional   view of T4Rad50 His-loop and Mre11 nuclease motif II (51-63) and III 
(79-97) interaction. The Walker A motif (Green) which binds to ATP occurs adjacent to 
the His-loop (Red). (b) Closer view of the interaction and the residues that could be 
involve in the electrostatic interaction.(c) Time course of amide exchange for 
Mre11peptide fragment 51-63 (m/z = 525.95, z = +3), (d) Rad50 fragment 532-548 (in 
complex-AMP_PNP) but 533-548 in others (e)Mre11 fragment 79-97 (m/z = 550.02, z= 
+4). The solid lines denote the best fit of the data to a one-phase association non linear 




























3.3.5 Flexibility of Rad50 coiled-coil segment undergoes changes upon AMP-PNP 
binding  
The N-terminal (189–198) and C-terminal (385–399 and, 400–409) base of coiled-coil 
segment of T4Rad50 and the CTD of T4Mre11 (311–326) showed a 40–50% decrease in 
deuteration after the complex formation (Figure 3.8A). This decrease corroborated our 
binding studies and showed that the CTD of T4MRe11 forms an interface with the 
T4Rad50 coiled-coil domain. It was even more interesting to observe a biomodal 
hydrogen-deuterium exchange profiles in the Rad50 N-terminal coiled-coil segment 
(168–188) that indicated that this region of Rad50 assumes multiple conformations. The 
MR Complex formation was found to select one of the conformations (Figure 3.13A). 
Furthermore, the coiled-coil segment is driven to yet another conformation upon AMP-
PNP binding, resulting in a slight increase of deuteration than in the complex but 
decrease from the free T4Rad50 deuteration levels (Figure 3.13A and B). A similar 
increase in deuteration levels was also observed in the C-terminal coiled-coil fragment 
(385–399) post AMP-PNP binding) (Figure 3.13D). AFM studies on the human MR 
complex previously showed that binding of AMP-PNP does not affect the flexibility of 
the coiled-coil segment (77). Contrary to this, our deuterium exchange data on T4MR 
reveals that the coiled-coil segment indeed undergoes small scale conformational changes 
that suggest flexibility in the coiled-coil segment. The mutations in this interface in the 
TmMR complex have been previously shown to affect the nuclease activity (42). 
Although structural studies so far highlight the global translational shift in the position of 
the coiled-coil segment, little is known about the internal conformational changes in the 
coiled-coil segment. Amide exchange data revealed that there are internal changes 
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occurring within the coiled-coil base segment which when disrupted could affect the 
nuclease activity of T4Mre11. 
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Figure 3.13: Conformational changes at the T4Mre11-Rad50 interface II. (a) Time series 
(0-10mins) spectra of T4Rad50 peptide fragment 168-188 in apo T4Rad50 protein 
showing bimodal distribution indicating presence of more than one conformation. (b) 
Comparison of amide exchange at 10min time point (168-188) in free protein, after 
complex formation and post AMP-PNP binding. The spectra shows absence of biomodal 
distribution after complex formation and an increase in amide exchange rate post AMP-
PNP binding when compared to complex. (c) Mapping of the segments which show 
changes in amide exchange profile post AMP-PNP binding in the C-terminal domain of 
Mre11 and coiled-coil segment of Rad50 at the interaction interface. These segments 
undergo conformational changes which are otherwise not visible in the crystal structure. 
(d) Time series of amide exchange of T4Rad50 C-terminal coiled-coil segment 385-399 
(m/z = 591.35, z = +3), e. 400-409 (m/z = 623.34, z = +2) (f) Mre11 C-terminal fragment 
310-326 (m/z = 969.7, z= +2). The solid lines denote the best fit of the data to a one-












3.3.6 Effect of AMP-PNP on the distal coiled-coil segments 
The coiled-coil segment of Rad50 is known to communicate with the globular NBDs of 
Rad50 and play an important role in maintaining the integrity of MR complex (46). In the 
structural studies conducted so far, the coiled-coil segment of Rad50 except for the 
minimal fragment required for Mre11 binding of Rad50 has been consistently eliminated 
to avoid aggregation. However, the low working protein concentrations require for the 
deuterium exchange experiments allowed us to retain the full length T4Rad50 to study 
the effect of AMP-PNP in the distal regions of the coiled-coil segment. The deuterium 
exchange profile of this segment (200–375) (Figure 3.8A) highlights that most of the 
peptide fragments, except the fragment 200–216, do not show any change in deuteration 
levels upon complex formation ( Appendix E ). Fragment 200–216 which lies adjacent to 
the N-terminal base of coiled-coil of the interface II, was found to show close to 40% 
decrease in the deuteration level. No change in the deuteron uptake level in the rest of the 
segment suggested that there are no significant changes occurring in the distal coiled-coil 
segment of Rad50 due to binding of Mre11. However, all of the segments covering the 
coiled-coil segment (200–375) showed an increase in the deuteration level post AMP-
PNP binding, suggesting the occurrence of a conformational change along the entire 
coiled-coil segment (Appendix E). These changes highlight that the distal coiled-coil 
segments could play a role in the functioning of the complex which is supported by a 





3.4 Hydrolysis of ATP is essential for substrate processing by T4Mre11 dsDNA  
Furthermore, AFM was employed to examine the DNA-binding activity and structural 
organization of the T4MR–DNA complex. The AFM images identified that the T4MR 
complex does not bind the DNA substrate in the absence of ATP (Figure 3.14), 
suggesting that the lack of T4Mre11 nuclease activity in the absence of ATP is due to the 
inability of the MR complex to bind the substrate. Although the quaternary structure of 
MR complex was not clearly discernible, we were able to identify that the MR complexes 
bound multiple strands of DNA together into a bundle (Figure 3.14E and F). In line with 
the biological activity of a MR complex to join together DNA ends for DSB repair, these 
MR–DNA complexes were frequently observed at the ends of the DNA substrates 
(Figure 3.14E). Interestingly, when ATPγS was used in place of ATP, the MR complex–
DNA bundle formation was not observed despite that the MR complexes were found to 
be associated with DNA (Figure 3.14D). These results indicate that T4MR complex 
requires ATP to bind to the DNA substrate, but hydrolysis of ATP is required to bring 
DNA strands together. Unlike the MjMR complex where ATP-bound Rad50 is found to 
downregulate  the MjMre11 endonuclease activity, T4MR appears to behave similar to 








                  
Figure 3.14: Atomic Force Microscope analysis of T4Mre11 and Rad50 and DNA 
binding interaction. (a) The linear PhiX174 DNA that was used in binding interactions. 
(b and c) Reaction mixtures of linear PhiX174 DNA incubated with purified MR 
complex at DNA/protein ratios of 1:100(b) and 1:1000(c), respectively. No obvious 
binding activity was observed in both conditions. (d) Reaction mixtures of linear 
PhiX174 DNA incubated with purified MR complex at DNA/protein ratio of 1:100 in the 
presence of 1 mM ATPγS.  Dots on backbone of DNA fragments may indicate MR 
complex bound to DNA. (e and f) Reactions with linear PhiX174 DNA, incubated with 
purified MR complex at DNA/protein ratios either of 1:30(e), or 1:100(f) in the presence 
of 1 mM ATP. Flower structure composed of multiple inner loops within one DNA 
molecule was observed at DNA/protein ratio of 1:30.  Bundle formation was observed at 
DNA/protein ratio of 1:100. Arrows indicate the protein bound to DNA. The scale bars 






















Mre11–Rad50 complex has been extensively studied over the last two decades. The 
assembly and coordinated functioning of this robust cellular DNA repair motor has been 
unraveled to a great extent. Studies have highlighted both the conserved nature of 
domains within the complex and diversity in its organization (79). Although archeal MR 
crystal structures have been reported and several biophysical studies on truncated 
versions of the complex have been carried out (38, 42, 44, 50, 65, 80), the precise pathway 
of communication between the two proteins remains a mystery. More recently, multiple 
evidences of a long range allosteric regulation of Mre11 nuclease activity by Rad50 have 
been put forth (50, 65, 76). Our study on the T4MR complex highlights the segments of 
Mre11 and Rad50 that undergo dynamic rearrangements during the complex formation 
and after AMP-PNP binds to the Rad50 dimer interface. Some of these dynamic 
segments have been previously shown to play a role in allosteric communication (43, 50). 
However, those previous studies were limited by the use of Rad50 mutants lacking the 
coiled-coil region to avoid coiled-coil-mediated aggregation at the protein concentration 
required for the structural studies. The use of HDXMS technique allowed us to perform 
the experiments a low protein concentration, allowing the use an intact protein in our 
biochemical assays.  
When analyzed at a whole-protein level using amide exchange patterns, both proteins are 
conformationally stabilized during the MR complex formation. Furthermore, upon AMP-
PNP binding, the conformational flexibility of Rad50 increased, while Mre11 was 
stabilized further. When analyzed at peptide level, the exchange patterns revealed that 
small scale conformational changes were occurring at the MR complex interfaces and 
distal domains of Rad50 and Mre11. Because structural studies were inherently 
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insensitive to smaller dynamic behaviors of proteins, previous studies failed to detect 
those conformational shifts we were able to observe in the MR complex. 
AFM studies of T4MR show that ATP is essential for DNA substrate binding, suggesting 
that the binding site is not accessible for the substrate in the absence of ATP (Figure 
3.14). This speculation was further supported by the lower amide exchange rates 
observed at the Rad50 dimer interface which suggest that it exists in a closed 
conformation, thereby preventing the substrate to access the nuclease site. ATP 
hydrolysis is known to drive the open–close conformation transition of Rad50 (81). It is 
interesting to observe that the AFM studies also showed that the T4MR complex still 
binds the substrate in the presence of ATPγS in (Figure 3.14d). This could be explained 
by the ability of ATPγS to hold the Rad50 dimers in an open conformation in a similar 
fashion as AMP-PNP, which would allow the substrate to be seated in the binding pocket. 
The closed conformational state (in the absence of ATP) is physiologically relevant as it 
would block random substrates from binding the active site. This could prevent 
anomalous activity of the MR complex, hence serving as a checkpoint for the T4MR 
activity. Based on these observations, we propose a model for the functioning of the 
T4MR complex (Figure 4.1). The model highlights the domain orientation of the 
constituent proteins within the complex forming a closed conformation (Figure 4.1A) and 
the AMP-PNP-bound form assuming an open conformation (Figure 4.1B). Another 
interesting observation is the bundling of T4MR complex observed in the presence of 
ATP in the AFM studies. This bundling behavior is similar to what has been observed in 
human and S. cerevisiae MR complexes which form large multimers (79). This is, 
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however, not seen in prokaryotic MR complexes, suggesting that T4MR may function in 






Figure 4.1: Model for T4MR complex (a) Complex in free form, is prevented from 
binding to DNA substrate as the Rad50 dimers are closer. (b) Complex bound to AMP-
PNP which locks the complex in an open conformation similar to what has been observed 
in PfMR complex. This transition allows the substrate recognition to occur. Pink: Mre11 
domains, Blue: Rad50 domains. Mre11 nuclease domain (   ), capping domain (      ), 
linker region (    ), RBD  (     ), N-terminal domain (     ), C-terminal domain (     ), coiled-
coil segment (      ,        ). 
 
Until now, only a little attention has been paid to the coiled-coil domain in investigating 
the function of the MR complex. The length of this domain is variable, and the sequence 
is far less conserved compared to the globular domain. However, a high structural 
similarity of this domain is observed amongst various eukaryotic and prokaryotic species. 
Different orientations of the coiled-coil segment with respect to the globular domain have 
been observed during AFM studies (79). These arrangements amongst various species 
have been used to explain the diverse cellular activities carried out by MR complex (79). 
Until a decade ago, the coiled-coil segment of Rad50 was thought to be a stiff structural 
element. Hence, researchers were unable to explain some of the unfavorable orientations 




b. T4Mre11-Rad50-AMP-PNP  






observed in AFM studies (79). However, a study by John et al. revealed that the coiled-
coil segment of Rad50 harbors segments of higher flexibility (lower coiled-coil 
probability) which could, for example, explain the occurrence of the ring formation of 
coiled-coil segment observed in hRad50 structures (arising out attachment at the Zn motif 
and globular domain)(82).Truncation studies of coiled-coil segment is also found to alter 
the complex nuclease activities suggesting that this domain is essential. Our amide 
exchange data supported John et al.’s observations. We observed an alternating fashion 
of deuterium exchange pattern along the coiled-coil segment (Appendix E). In addition to 
that, the data also revealed that this flexibility is further affected by the AMP-PNP-
binding event. A consistent increase in deuteron uptake levels all along the segment 
suggests that the flexibility of the coiled-coil segment increases upon AMP-PNP-binding 
(Figure 3.9B, appendix E). This confirmed that AMP-PNP binding leads to 
conformational changes at the distal end of the coiled-coil segment. This increase in the 
coiled-coil conformational flexibility explains the formation of some of the otherwise 
unfavorable MR arrangements seen in AFM structures. It also explains the ability of MR 
complexes to recruit and orient template DNA for repair during homologous 
recombination or to orient the N and C lobes of Rad50 to facilitate the entry of the 
damaged substrates of various sizes into the active site.  
Sufficient evidences has been put forth to establish allosteric regulation of Mre11 
nuclease activity by Rad50. And these were obtained using crystal structures and 
mutational studies in the fragments which showed visible conformational changes. 
However, our study revealed that, apart from the large time-scale conformational 
changes, there are other small time-scale changes which play a crucial role in MR 
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allostery. These include the changes highlighted in our study across the interfaces and 
coiled-coil segment. Thus, Mre11 activity is found to be controlled through multiple sites 
involving the terminals and distal regions of the coiled-coiled domain, the signature motif 
and His-switch of Rad50 as well as the Mre11 capping domain, and there could be others 
which are not arising due to their non-visible nature (83). These findings suggest that 
Rad50 could regulate the Mre11 activity allosterically through multiple pathways as 
observed in other systems (84). MR complex is an example of protein machinery where 
combination of both protein dynamics and conformational redistribution plays an 
important role in allosteric regulation(85, 86).  
Recent drug discovery efforts have shifted from targeting the active site to trapping the 
protein targets in an inactive conformation (87). These drugs are designed primarily by 
targeting allosteric regulation sites within the proteins. Occurrence of more than one 
allosteric site increases the number of viable drug targets, hence increasing the chance of 
successfully deactivation of the target proteins. Our findings here lay a platform for 
designing allosteric drugs against MR complex. These drugs could be used to selectively 
sensitize cancer cells by disrupting MR complex and increase the potency of 
chemotherapeutic agents or radiotherapy, an approach which has been repeatedly 
studied(88, 89).Combination therapy constituting ligands targeting the various allosteric 
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Figure 1: Mre11 alignment 
           
Motif                      I                                      II 
T4Mre11 ............MKILNLGDWHLGVKADDEWIRGIQI.DGIKQAIEYSKKNGITTWIQYGDIFDVRKAIT  
pfMre11 ............MKFAHLADIHLGYEQFHKPQREEEFAEAFKNALEIAVQENVDFILIAGDLFHSSRPSP  
hMre11    MSTADALDDENTFKILVATDIHLGFME.KDAVRGNDTFVTLDEILRLAQENEVDFILLGGDLFHENKPSR  
scMRE11 MDYPDP....DTIRILITTDNHVGYNE.NDPITGDDSWKTFHEVMMLAKNNNVDMVVQSGDLFHVNKPSK  




Motif                                                          III 
T4Mre11 HKTMEFAREIVQ................................TLDDAGITLHTIVGNHDLHYKNVMHP  
pfMre11 GTLKKAIALLQI.................................PKEHSIPVFAIEGNHDRTQRGP..S  
hMre11 KTLHTCLELLRKYCMGDRPVQFEILSDQSVNFGFSKFPWVNYQDGNLNISIPVFSIHGNHDDPTGADALC  




       
Motif  
T4Mre11 NASTELLAKY..PNVKVY................DKPTTVDFDGCLIDLIPWMCEENTGEILEHIKTSSA 
pfMre11 VLNLLEDFGLVYVIGMRKEKVENEYLTSERLGNGEYLVKGVYKDLEIHGMKYM....SSAWFEANKEI..  
hMre11 ALDILSCAGFVNHFGRSMSVEKIDISPVLLQKGSTKIALYGLGSIPDERLY....RMFVNKKVTML....  





Motif                    IV                                     V 
T4Mre11 .SFCVGHWELNGFYFYKGMKSHG...................LEPDFLKTYKEVWSGHFH..........  
pfMre11 LKRLFRPTDNAILMLHQGVREVSEARGEDYFEIGLGD.....LPEGYL....YYALGHIH..........  
hMre11 RPKEDENSWFNLFVIHQ......NRSKHGSTNFIPEQ.....FLDDFID..LVIW.GHEHECKIA.....  





Motif                  VI 
T4Mre11 ..T.ISEAAN...VRYIGTPWTLTAGDENDPR...............GFWMFDT...ETERTEFIPNNTT  
pfMre11 ..KRYETSYSGSPVVYPGSLERWDFGDYEVRYEWDGIKFKERYGVNKGFYIVEDF.......KPRFVEIK 
hMre11 PTKNEQ...QLFYISQPGSSVVTSLSPGEA..............VKKHVGLLRIKGRKMNMHKIPLHTV.  





T4Mre11   WHRRIHYPFK...................GKIDYKDFTNLSVR...........VIVTEVD....KNLT 
pfMre11   VRPFIDVKIK..............GSEEEIRKAIKRLIPLI.........PKNAYVRLNIGWRKPFDLT  
hMre11    .RQFFMEDIVLANHPDIFNPDNPKVTQAIQSFCLEKIEEMLENAER....PEKPLVRLRVD....YSGG 
scMre11   .RTFKMKSISLQDVPHL....RPHDKDATSKYLIEQVEEMIRDANE....LPKPLIRLRVD....YSAP 








T4Mre11   ...........KFESELEKVVHSLRVVSKIDN...SVESDDSEEVEVQSLQTLMEEYIN........AI 
pfMre11   ...........EIKELLN..VEYLKIDTWR.....IKERTDEESGKIGLPSDFFTEFELKI.....IDI 
hMre11    ........FEPFSVLRFSQKFVDRVANPKDII---GKLITKPSEGTTLRVEDLVKQYFQTAEKNVQLSL 
scMre11   SNTQSPIDYQVENPRRFSNRFVGRVANGNNVV---DVEKLFSESGGELEVQTLVNDLLNKM....QLSL  





T4MRE11   P.DITDSDREALIQYAN.........QLYVEATQ    339 
PfMre11   LGEKDFDD.FDYIIKLITEGKVEEGPLEEAVKKVSEEKGKT   402 
hMre11    LTERGMGEAVQEFVDKEEKD.....AIEELVKYQLEKTQRF  484 
ScMre11   LPEVGLNEAVKKFVDKDEKT.....ALKEFISHEISNEVGI           497 
MjMre11   DGDLVLSLYKALLNNEN.........WKELLDEYYNTKFRG   366   
 
 
Figure 2: Rad50 alignment 
Motif                                 Walker A (P-loop)  
 
 
T4Rad50 .MKNFKLNRVKYKNIMSVGQNGIDIQLDKVQ.KTLITGRNGGGKSTMLEAITFGLFGKPFRDVKKGQLIN   
pfRad50 ....MKLERVTVKNFRSHSDTVVEFKEG....INLIIGQNGSGKSSLLDAILVGLY...WPLRIKDIKKD  
hsRad50 MSRIEKMSILGVRSFGIEDKDKQIITFFSP..LTILVGPNGAGKTTIIECLKYICTGDFPPGTKGNTFVH   




T4gp46 S...TNKKELLVELWMEYDE.........KKYYIKRGQKPNVF........EITVNGTRLNESASSKDFQ  
pfRad50 EFTKVGARDTYIDLIFEKDG..........TKYRITRRFLKGYSSGEIHAMKRLVGNEWKHVTEPSSKAI  
hsRad50 DPKVAQETDVRAQIRLQFRDVNGELIAVQRSMVCTQKSKKTEFKTLEG.VITRTKHGEKVSLSSKCAEID   
scRad50 DPKITGEKDIRAQVKLAFTSANGLNMIVTRNIQLLMKKTTTTFKTLEGQLVAINNSGDRSTLSTRSLELD   
MjRad50 T...KGKKSVYVELDFEVNG.........NNYKIIREYDSGRG........GAKLYKNGKPYATTISAVN 
 
Motif                    Q-loop  
 
T4gp46 AEFEQLIGMSYASF......KQIVVLGTAGYTPFMGLSTPARRKLVEDLLEVGTLAEMDKLNKALIRELN 
pfRAD50 SAFMEKL.IPYNIFLNAIYIRQGQIDAILE..........SDEAREKVVREVLNLDKFETAYKKLSELKK  
hsRad50 REMISSLGVSKAVLNNVIFCHQEDSNWPLS..........EGKALKQKFDEIFSATRYIKALETLRQVRQ  
scRad50 AQVPLYLGVPKAILEYVIFCHQEDSLWPLS..........EPSNLKKKFDEIFQAMKFTKALDNLKSIKK  
MjRad50 KAVNEILGVDRNMFLNSIYIKQGEIAKFLSL.........KPSEKLETVAKLLGIDEFEKCYQKMGEIVK 
 










                                  
 
T4gp46 LQEELDKIVKTKTNLVMEKYHRGILTDMLKDSGIKGAIIKKYIPLFNKQINHYLKIM............. 










hsRad50 VSASDKRRNYNYRVVMLKGDTALDMRGRCSAGQKVLASLIIRLALAETFC....LNCGIIALDEP.....   




Motif  D-loop                        H-loop  
 
T4gp46 DGSFDAEGIKGVA.....NIINSMKNTN..VFIISHKDHDPQE  
pfRAD50 TPYLDEERRRKLI.....TIMERYLKKIPQVILVSHDEELKDA 
hsRad50 TTNLDRENIESLAHALVEIIKSRSQQRNFQLLVITHDEDFVEL  






















MKILNLGDW 1-9 545.29 2 8 0.9±0.01 1.2±0.06 0.85±0.15 
MKILNLGDWHL 1-11 670.36 2 10 1.5±0.02 1.4±0.07 1.1±0.1 
MKILNLGDWHLGVKADDE 1-18 685.36 3 17 4.0±0.02 4.0±0.03 3.1±0.3 
WIRGIQIDGIKQ 19-30 713.91 2 11 1.1±0.01 0.8±0.1 0.75±0.25 
WIRGIQIDGIKQAIE 19-33 580.67 3 14 2.7±0.06 0.7±0.2 0.5±0.3 
IQYGDIF 45-50 855.42 1 5 1.2±0.01 1.30±0.01 0.7±0.3 
DVRKAITHKTME 51-62 476.92 3 11 5.7±0.06 5.1±0.19 5.5±0.3 
DVRKAITHKTMEF (I) 51-63 525.95 3 12 5.9±0 5±0.06 4.6±0.3 
HTIVGNHDLHYKNVMHPNA(II) 79-97 550.03 4 17 4.5±0.01 5.3±0.3 3.7±0.1 
LAKYPNVKVYDKPTTVDF 102-119 700.05 3 15 4.6±0.01 4.1±0.02 5.22±0.1 
CEENTGEILE 131-140 1136.48 1 9 3.5±0.15 4.06±0 3.1±0.2 
ENTGEILE 133-140 904.42 1 7 2.6±0.02 3.1±0.05 2.3±0.1 
FCVGHWELNGF 149-159 654.80 2 10 3.7±0.03 4.5±0.06 4.3±0.1 
CVGHWELNGF 150-159 581.26 2 9 3.8±0.02 4.5±0.02 4.2±0.1 
CVGHWELNGFY 150-160 662.79 2 10 4.6±0.1 5±0.02 4.7±0.2 
FYKGMKSHGLEPDF (III) 161-174 828.40 2 12 4.2±0.03 5±0.2 4.2±0.1 
YKEVWSGHFHTISE (IV) 178-191 860.414 2 13 2.5±0.1 3.8±0.1 1.3±0.1 
VRYIGTPWTLTAGDENDPRGF(V) 195-215 789.06 3 18 6.9±0.05 8.2±0.01 6.2±0.1 
IHYPFKGKIDYKDFTNL 238-254 700.38 3 15 3.8±0.1 3.7±0.1 
 
PNNTTWHRRIHYPFKGKIDYKDFTNL 229-254 816.181 4 23 
  
8.5±0.1 
EVDKNLTKF 262-270 547.30 2 8 5.5±0.1 3.6±0.11 5.5±0.1 
RVVSKIDNSVESDDSEE 282-292 954.447 2 16 10.2±0.1 12.61±0.1 10.4±0.2 
EYINAIPDITDSDREAL 310-326 967.97 2 15 11.2±0.03 1.5±0.1 2.5±0.2 

















Average and standard deviations were calculated using measurements from three independent experiments.  
Peptides highlighted are those harboring the nuclease motifs of Mre11. 
APPENDIX E: Rad50 peptides 
Peptide fragment 












SVGQNGID 16-23 789.37 1 7 4.0±0 3.5±0.2 3.6±0.3 
DKVQKTLITGRNGGGKSTML 27-46 526.79 4 19 12.4±0.2 9.4±0.5 8.11±0.1 
EAITFGL 47-53 750.40 1 6 0.3±0 0.3±0 0.34±0.03 
ITFGLFGKPFRDVKKGQLINSTNKKELL 50-76 639.18 2 25 10.9±0.2 9.8±0.4 12.52±0 
INSTNKKEL 67-75 523.79 3 8 2.4±0.1 1.8±0.1 4.0±0.3 
WMEYDEKKYYIKRGQKPNVFE 80-100 551.08 5 20 3.4±0.1 3.1±0.1 4.7± 0.2 
NESASSKDFQAEF 109-121 730.32 2 12 7.1±0.1 6.6±0.2 7.9±0.1 
KQIVVLGTAGYTPFMG 133-148 841.45 2 15 8.5±0.2 7.6±0.3 9.7±0.1 
LSTPARRKLVEDLL 149-161 886.51 2 11 2.5±0.1 1.5±0 2.9±0.1 
DVKKDSIIQQ 189-198 587.33 2 9 5.7±0.1 0.6±0.1 1.1±0 
KIYNDNVERQKKLTGDNL 200-217 537.79 4 17 11.1±0.3 4.8±0.1 8.69±0.1 
LTRLQNM 217-223 438.24 2 6 1.8±0 1.9±0.1 2.7±0.1 
YDDLAKEARTLKSEIEEANERLVN 224-247 702.37 4 23 1.3±0 1.3±0.1 2.7±0.1 
DEDPTDAFNKIGQEAFL 251-267 955.45 2 15 3.2±0.1 2.7±0 6.3±0.3 
FLIKSKIDSYNKVINM 266-281 638.36 3 15 1.0±0 1.0±0.1 3.07±0 
YHEGGLCPTCL 282-292 596.76 2 9 1.4±0 1.4±0.1 1.7±0 
SSGDKVVSKIKDKVSE 296-311 569.32 3 15 7.1±0 6.6±0.2 7.6±0 
LSTHRDN 319-325 421.71 2 6 1.4±0 1.1±0.1 1.2±0.1 
YRDNIKTQQSLAND 332-346 833.41 2 14 1.6±0.1 1.5±0.1 5±0.1 














Average and standard deviations were calculated using measurements from three independent experiments.  







IAAVDKAKKVKAAIE 354-369 518.99 3 15 1.5±0.1 1.4±0.1 3.8±0.2 
LQEELDKIVKTKTNL 385-399 886.51 2 14 6.5±0.1 1.3±0.1 4.2±0.3 
VMEKYHRGIL 400-409 623.34 2 9 4.3±0.1 0.8±0.0 0.5±0.1 
LKDSGIKGAIIKKYIPLFNKQINHY 413-437 581.15 5 24 6.5±0.2 1.9±0.1 6.7±0.3 
TLDEEF 448-453 753.33 1 5 0.9±0.1 0.9±1 1.5±0.2 
NETIKSRGREDFS 454-468 769.88 2 12 7.5±0.1 6.7±0.3 8±0.5 
ASFSEGEKARIDIAL 468-482 803.93 2 14 2.7±0.08 2.8±0.0 5.3±0.1 
FTWRDIAS 484-491 498.25 2 7 0.3±0 0.2±0 
 
FTWRDIASIVSGVS 484-497 760.43 1 13 
  
3.96±0.1 
ILDEVFDGSF 502-511 571.26 2 9 1.1±0 1.6±0.1 5.4±0.1 
DAEGIKGVANIINS 512-515 700.87 2 13 9.0±0.01 7.8±0.2 10±0.5 
IISHKDHDPQEYGQHLQM 533-550 726.02 3 17 7.4±0 5.9±0.1 5.8±0.2 
  
 
 
 
 
 
